Investing
The gold price saw peaks and troughs this week. After rising to almost US$3,350 per ounce on Monday (May 26), the yellow metal took...
Connect with us
Hi, what are you looking for?
Daily Market Solution
- Stock
U.S. foreign tax bill sends jitters across Wall Street
Amazon taps Xbox co-founder to lead new team developing ‘breakthrough’ consumer products
Nvidia results spark global chip rally
Boeing to resume airplane deliveries to China next month, ramp up Max production, CEO says
E.l.f. Beauty to acquire Hailey Bieber skin care brand Rhode in up to $1 billion deal
- Economy
- Editor’s Pick
Trump’s exaggerated claim that Pennsylvania has 500,000 fracking jobs
Tucker Carlson says father Trump will give ‘spanking’ at rowdy Georgia rally
A GOP operative accused a monastery of voter fraud. Nuns fought back.
American creating deepfakes targeting Harris works with Russian intel, documents show
Early voting in Wisconsin slowed by label printing problems
- Latest News
Trump warns Rand Paul he’s playing into ‘hands of the Democrats’ with ‘Big, Beautiful Bill’ opposition
White House urges Iran to accept nuclear deal as IAEA reports uranium enrichment spike
Israel hostage deal in doubt as Hamas adds demands, US envoy calls terms ‘unacceptable’
Iran condemns Austria over report on advanced nuclear weapons program
ROBERT MAGINNIS: 9 signs Beijing’s Taiwan invasion may be imminent
Investing
The gold price saw peaks and troughs this week. After rising to almost US$3,350 per ounce on Monday (May 26), the yellow metal took...
Investing
The gold price saw peaks and troughs this week. After rising to almost US$3,350 per ounce on Monday (May 26), the yellow metal took...
Investing
When the US Food and Drug Administration (FDA) rejected Lykos Therapeutics’ new drug application for MDMA-assisted therapy last August, the initial disappointment cast a...
Investing
When the US Food and Drug Administration (FDA) rejected Lykos Therapeutics’ new drug application for MDMA-assisted therapy last August, the initial disappointment cast a...
Investing
When the US Food and Drug Administration (FDA) rejected Lykos Therapeutics’ new drug application for MDMA-assisted therapy last August, the initial disappointment cast a...
Investing
When the US Food and Drug Administration (FDA) rejected Lykos Therapeutics’ new drug application for MDMA-assisted therapy last August, the initial disappointment cast a...
Investing
When the US Food and Drug Administration (FDA) rejected Lykos Therapeutics’ new drug application for MDMA-assisted therapy last August, the initial disappointment cast a...
Investing
When the US Food and Drug Administration (FDA) rejected Lykos Therapeutics’ new drug application for MDMA-assisted therapy last August, the initial disappointment cast a...
Investing
When the US Food and Drug Administration (FDA) rejected Lykos Therapeutics’ new drug application for MDMA-assisted therapy last August, the initial disappointment cast a...
Investing
When the US Food and Drug Administration (FDA) rejected Lykos Therapeutics’ new drug application for MDMA-assisted therapy last August, the initial disappointment cast a...
Investing
NorthStar Gaming Holdings Inc. (TSXV: BET) (OTCQB: NSBBF) (‘NorthStar’ or the ‘Company’) today announces that its principal regulator, the Ontario Securities Commission, has granted...
Investing
NorthStar Gaming Holdings Inc. (TSXV: BET) (OTCQB: NSBBF) (‘NorthStar’ or the ‘Company’) today announces that its principal regulator, the Ontario Securities Commission, has granted...
Investing
Wide Open Agriculture (WOA:AU) has announced $2.6M Placement and SPP to fast-track China entry and sales Download the PDF here. This post appeared first...
Investing
Wide Open Agriculture (WOA:AU) has announced $2.6M Placement and SPP to fast-track China entry and sales Download the PDF here. This post appeared first...